Workflow
Hologic(HOLX)
icon
Search documents
Hologic (HOLX) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow
2023-01-11 18:41
3 Introduction Elevating Global Women's Health… • 4th for large companies in San Diego County by The San Diego Union-Tribune 2 Non-GAAP Financial Measures The Company has presented the following non-GAAP financial measures in this presentation: constant currency revenues; organic revenues; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net margin; non-GAAP EPS; and adjusted EBITDA. Constant currency calculations show ...
Hologic(HOLX) - 2022 Q4 - Annual Report
2022-11-14 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 24, 2022 or For the transition period from to Commission File Number: 1-36214 __________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: HOLOGIC, INC. (Exact ...
Hologic(HOLX) - 2022 Q4 - Earnings Call Transcript
2022-11-01 02:20
Hologic, Inc. (NASDAQ:HOLX) Q4 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Anthony Petrone - Mizuho Group Jack Meehan - Nephron Research Puneet Souda - SVB Securities Liza Garcia - UBS Max Masucci - Cowen and Company Tim Daley - Wells Fargo Derik de Bruin - Bank of America Casey Woodring - JPMorgan Oper ...
Hologic(HOLX) - 2022 Q3 - Earnings Call Transcript
2022-07-28 03:23
Hologic, Inc. (NASDAQ:HOLX) Q3 2022 Results Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Tejas Savant - Morgan Stanley Patrick Donnelly - Citigroup Nisarg Shah - Bank of America Merrill Lynch Vijay Kumar - Evercore ISI Joseph Conway - Needham & Company Puneet Souda - ...
Hologic(HOLX) - 2022 Q3 - Quarterly Report
2022-07-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 25, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC, ...
Hologic(HOLX) - 2022 Q2 - Earnings Call Transcript
2022-04-28 03:23
Hologic, Inc. (NASDAQ:HOLX) Q2 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Puneet Souda - SVB Securities Tejas Savant - Morgan Stanley Casey Woodring - JPMorgan Derik de Bruin - Bank of America Ryan Zimmerman - B ...
Hologic(HOLX) - 2022 Q2 - Quarterly Report
2022-04-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC ...
Hologic (HOLX) Investor Presentation - Slideshow
2022-03-04 22:02
| --- | --- | --- | |---------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | Growing Stronger by Delivering on Our Purpose, Passion and Promise | | | | February 2022 | | | Safe Harbor Statement 2 This presentation contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions. Such statements include, without limitation: financial or other info ...
Hologic(HOLX) - 2022 Q1 - Earnings Call Transcript
2022-02-03 03:17
Hologic, Inc. (NASDAQ:HOLX) Q1 2022 Earnings Conference Call February 2, 2022 4:30 PM ET Corporate Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Dan Leonard - Wells Fargo Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Brian Weinstein - William Blair Casey Woodring - JPMorgan Derik De Bruin ...
Hologic(HOLX) - 2022 Q1 - Quarterly Report
2022-02-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 25, 2021 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLO ...